Cargando…
Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme
Anticoagulants are recommended for the prevention and treatment of venous thromboembolism (VTE), prevention of stroke in patients with atrial fibrillation (AF) and secondary prevention in patients with acute coronary syndrome (ACS). There is a clinical need for novel anticoagulants offering improvem...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730547/ https://www.ncbi.nlm.nih.gov/pubmed/19187276 http://dx.doi.org/10.1111/j.1600-0609.2009.01230.x |